HK Stock MarketDetailed Quotes

02162 KEYMED BIO-B

Watchlist

35.300
+0.400+1.15%

Trading Apr 29 10:38 CST

9.87BMarket Cap-24894P/E (TTM)

KEYMED BIO-B Key Stats

Cash Flow

All

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q6)Jun 30, 2023

(FY)Dec 31, 2022

(Q6)Dec 31, 2022

(FY)Dec 31, 2021

(Q6)Dec 31, 2021

(FY)Dec 31, 2020

(Q6)Dec 31, 2020

(FY)Dec 31, 2019

Assets

Current assets

Inventory

26.65%56.35M

80.76%80.43M

171.43%44.5M

139.45%16.39M

107.08%6.85M

--6.85M

--3.31M

Accounts receivable

--16.09M

--5.62M

----

Advance deposits and other receivables

49.88%135.13M

-12.18%79.17M

143.68%90.15M

85.09%37M

23.77%19.99M

--19.99M

--16.15M

Cash and equivalents

40.88%851.03M

84.61%1.12B

-60.27%604.07M

662.56%1.52B

-53.91%199.41M

--199.41M

--432.61M

Fixed time deposit-current assets

-27.59%1.69B

-31.74%1.6B

19.92%2.34B

1,251.94%1.95B

--144.28M

----

Secured deposit

--1.78M

----

Financial assets at fair value-current assets

-24.90%174.37M

14.93%266.85M

334.80%232.19M

413.77%53.4M

-84.33%10.39M

--10.39M

--66.34M

Special items of current assets

--11M

--2.68M

----

--3.98M

----

Total current assets

-11.19%2.94B

-4.93%3.15B

-7.59%3.31B

840.35%3.58B

-26.52%380.92M

--380.92M

--518.41M

Non-current assets

Property, plant and equipment

45.12%803.35M

40.50%777.73M

297.04%553.56M

38.05%139.42M

4.69%100.99M

--100.99M

--96.47M

Advance payment

69.90%26.91M

12.93%17.89M

-89.69%15.84M

537.20%153.59M

62.80%24.1M

--24.1M

--14.81M

Interests in Joint Venture

-44.92%5.82M

-19.84%8.47M

-47.88%10.57M

--20.28M

----

Intangible assets

-25.80%1.11M

-12.90%1.3M

35.51%1.5M

912.84%1.1M

--109K

----

Special items of non-current assets

159.79%106.2M

182.99%115.68M

7.26%40.88M

59.98%38.11M

-17.57%23.82M

--23.82M

--28.9M

Total non-current assets

51.59%943.39M

48.00%921.08M

76.55%622.34M

136.54%352.51M

6.32%149.03M

--149.03M

--140.17M

Total assets

-1.26%3.88B

3.44%4.07B

-0.05%3.93B

642.43%3.93B

-19.53%529.95M

--529.95M

--658.58M

Liabilities

Current liabilities

Accounts payable

97.73%29.49M

128.44%34.07M

435.67%14.91M

-18.55%2.78M

-1.73%3.42M

--3.42M

--3.48M

Amounts payable to associated parties-current liabilities

----

-59.31%225K

-98.69%553K

-11.26%42.37M

--42.37M

--47.75M

Other payables and accrued expenses

50.09%219.44M

12.92%165.1M

53.25%146.21M

391.81%95.4M

33.83%19.4M

--19.4M

--14.5M

Bank loans and overdrafts

-25.08%45.83M

-80.78%11.76M

--61.16M

----

Financial lease liabilities-current liabilities

75.37%19.43M

62.73%18.03M

-5.51%11.08M

180.61%11.72M

-5.69%4.18M

--4.18M

--4.43M

Deferred income-current liabilities

----

-43.89%1.61M

99.51%2.87M

--2.87M

--1.44M

Special items of current liabilities

----

--146.11M

----

--8M

----

Total current liabilities

-17.26%314.18M

-39.70%228.95M

238.79%379.7M

39.67%112.08M

12.08%80.24M

--80.24M

--71.59M

Net current assets

-10.41%2.63B

-0.43%2.92B

-15.55%2.93B

1,054.02%3.47B

-32.71%300.68M

--300.68M

--446.82M

Total assets less current liabilities

0.45%3.57B

8.05%3.84B

-7.06%3.55B

749.97%3.82B

-23.39%449.71M

--449.71M

--586.99M

Non-current liabilities

Long-term bank loan

1,052.20%331.83M

841.33%271.1M

--28.8M

----

Financial lease liabilities-non-current liabilities

3.32%21.62M

45.81%30.52M

-22.45%20.93M

32.84%26.99M

-16.30%20.31M

--20.31M

--24.27M

Deferred tax liability

--278K

----

Deferred income-non-current liabilities

39.42%228.19M

-0.49%162.87M

1,777.18%163.67M

28.49%8.72M

327.60%6.79M

--6.79M

--1.59M

Convertible notes and bonds

----

88.99%1.39B

--1.39B

--733.26M

Other non-current liabilities

----

7.34%141.29M

26.79%131.64M

--131.64M

--103.82M

Total non-current liabilities

172.70%581.93M

117.66%464.48M

20.57%213.4M

-88.54%177M

78.98%1.54B

--1.54B

--862.94M

Total liabilities

51.09%896.11M

16.92%693.44M

105.17%593.1M

-82.21%289.07M

73.86%1.62B

--1.62B

--934.53M

Total assets less total liabilities

-10.55%2.99B

1.05%3.37B

-8.40%3.34B

432.97%3.65B

-296.73%-1.09B

---1.09B

---275.96M

Total equity and non-current liabilities

0.45%3.57B

8.05%3.84B

-7.06%3.55B

749.97%3.82B

-23.39%449.71M

--449.71M

--586.99M

Equity

Share capital

-0.59%169K

-0.58%170K

280.00%171K

0.00%45K

--45K

Reserve

-10.60%2.99B

1.01%3.37B

-8.51%3.34B

433.53%3.65B

--3.65B

---1.09B

----

Legal reserve

-10.60%2.99B

1.01%3.37B

-8.51%3.34B

433.53%3.65B

--3.65B

---1.09B

----

Special items of shareholders' rights and interests

100.00%2K

--1K

----

---1.09B

---276M

Shareholders' Equity

-10.60%2.99B

1.01%3.37B

-8.51%3.34B

433.56%3.65B

-296.64%-1.09B

---1.09B

---275.96M

Non-controlling interest

146.92%502K

110.09%108K

80.85%-1.07M

-2,008.68%-5.59M

---265K

----

Total equity

-10.55%2.99B

1.05%3.37B

-8.40%3.34B

432.97%3.65B

-296.73%-1.09B

---1.09B

---275.96M

Total equity and total liabilities

-1.26%3.88B

3.44%4.07B

-0.05%3.93B

642.43%3.93B

-19.53%529.95M

--529.95M

--658.58M

Currency Unit

CNY

Accounting Standards

IAS

Audit Opinions

Unqualified Opinion

Auditor

Ernst & Young

	(FY)Dec 31, 2023	(Q6)Jun 30, 2023	(FY)Dec 31, 2022	(Q6)Dec 31, 2022	(FY)Dec 31, 2021	(Q6)Dec 31, 2021	(FY)Dec 31, 2020	(Q6)Dec 31, 2020	(FY)Dec 31, 2019
Assets
Current assets
Inventory	26.65%56.35M	80.76%80.43M	171.43%44.5M	171.43%44.5M	139.45%16.39M	139.45%16.39M	107.08%6.85M	--6.85M	--3.31M
Accounts receivable	--16.09M	--5.62M	----	----	----	----	----	----	----
Advance deposits and other receivables	49.88%135.13M	-12.18%79.17M	143.68%90.15M	143.68%90.15M	85.09%37M	85.09%37M	23.77%19.99M	--19.99M	--16.15M
Cash and equivalents	40.88%851.03M	84.61%1.12B	-60.27%604.07M	-60.27%604.07M	662.56%1.52B	662.56%1.52B	-53.91%199.41M	--199.41M	--432.61M
Fixed time deposit-current assets	-27.59%1.69B	-31.74%1.6B	19.92%2.34B	19.92%2.34B	1,251.94%1.95B	1,251.94%1.95B	--144.28M	--144.28M	----
Secured deposit	--1.78M	----	----	----	----	----	----	----	----
Financial assets at fair value-current assets	-24.90%174.37M	14.93%266.85M	334.80%232.19M	334.80%232.19M	413.77%53.4M	413.77%53.4M	-84.33%10.39M	--10.39M	--66.34M
Special items of current assets	--11M	--2.68M	----	----	--3.98M	--3.98M	----	----	----
Total current assets	-11.19%2.94B	-4.93%3.15B	-7.59%3.31B	-7.59%3.31B	840.35%3.58B	840.35%3.58B	-26.52%380.92M	--380.92M	--518.41M
Non-current assets
Property, plant and equipment	45.12%803.35M	40.50%777.73M	297.04%553.56M	297.04%553.56M	38.05%139.42M	38.05%139.42M	4.69%100.99M	--100.99M	--96.47M
Advance payment	69.90%26.91M	12.93%17.89M	-89.69%15.84M	-89.69%15.84M	537.20%153.59M	537.20%153.59M	62.80%24.1M	--24.1M	--14.81M
Interests in Joint Venture	-44.92%5.82M	-19.84%8.47M	-47.88%10.57M	-47.88%10.57M	--20.28M	--20.28M	----	----	----
Intangible assets	-25.80%1.11M	-12.90%1.3M	35.51%1.5M	35.51%1.5M	912.84%1.1M	912.84%1.1M	--109K	--109K	----
Special items of non-current assets	159.79%106.2M	182.99%115.68M	7.26%40.88M	7.26%40.88M	59.98%38.11M	59.98%38.11M	-17.57%23.82M	--23.82M	--28.9M
Total non-current assets	51.59%943.39M	48.00%921.08M	76.55%622.34M	76.55%622.34M	136.54%352.51M	136.54%352.51M	6.32%149.03M	--149.03M	--140.17M
Total assets	-1.26%3.88B	3.44%4.07B	-0.05%3.93B	-0.05%3.93B	642.43%3.93B	642.43%3.93B	-19.53%529.95M	--529.95M	--658.58M
Liabilities
Current liabilities
Accounts payable	97.73%29.49M	128.44%34.07M	435.67%14.91M	435.67%14.91M	-18.55%2.78M	-18.55%2.78M	-1.73%3.42M	--3.42M	--3.48M
Amounts payable to associated parties-current liabilities	----	----	-59.31%225K	-59.31%225K	-98.69%553K	-98.69%553K	-11.26%42.37M	--42.37M	--47.75M
Other payables and accrued expenses	50.09%219.44M	12.92%165.1M	53.25%146.21M	53.25%146.21M	391.81%95.4M	391.81%95.4M	33.83%19.4M	--19.4M	--14.5M
Bank loans and overdrafts	-25.08%45.83M	-80.78%11.76M	--61.16M	--61.16M	----	----	----	----	----
Financial lease liabilities-current liabilities	75.37%19.43M	62.73%18.03M	-5.51%11.08M	-5.51%11.08M	180.61%11.72M	180.61%11.72M	-5.69%4.18M	--4.18M	--4.43M
Deferred income-current liabilities	----	----	----	----	-43.89%1.61M	-43.89%1.61M	99.51%2.87M	--2.87M	--1.44M
Special items of current liabilities	----	----	--146.11M	--146.11M	----	----	--8M	--8M	----
Total current liabilities	-17.26%314.18M	-39.70%228.95M	238.79%379.7M	238.79%379.7M	39.67%112.08M	39.67%112.08M	12.08%80.24M	--80.24M	--71.59M
Net current assets	-10.41%2.63B	-0.43%2.92B	-15.55%2.93B	-15.55%2.93B	1,054.02%3.47B	1,054.02%3.47B	-32.71%300.68M	--300.68M	--446.82M
Total assets less current liabilities	0.45%3.57B	8.05%3.84B	-7.06%3.55B	-7.06%3.55B	749.97%3.82B	749.97%3.82B	-23.39%449.71M	--449.71M	--586.99M
Non-current liabilities
Long-term bank loan	1,052.20%331.83M	841.33%271.1M	--28.8M	--28.8M	----	----	----	----	----
Financial lease liabilities-non-current liabilities	3.32%21.62M	45.81%30.52M	-22.45%20.93M	-22.45%20.93M	32.84%26.99M	32.84%26.99M	-16.30%20.31M	--20.31M	--24.27M
Deferred tax liability	--278K	----	----	----	----	----	----	----	----
Deferred income-non-current liabilities	39.42%228.19M	-0.49%162.87M	1,777.18%163.67M	1,777.18%163.67M	28.49%8.72M	28.49%8.72M	327.60%6.79M	--6.79M	--1.59M
Convertible notes and bonds	----	----	----	----	----	----	88.99%1.39B	--1.39B	--733.26M
Other non-current liabilities	----	----	----	----	7.34%141.29M	7.34%141.29M	26.79%131.64M	--131.64M	--103.82M
Total non-current liabilities	172.70%581.93M	117.66%464.48M	20.57%213.4M	20.57%213.4M	-88.54%177M	-88.54%177M	78.98%1.54B	--1.54B	--862.94M
Total liabilities	51.09%896.11M	16.92%693.44M	105.17%593.1M	105.17%593.1M	-82.21%289.07M	-82.21%289.07M	73.86%1.62B	--1.62B	--934.53M
Total assets less total liabilities	-10.55%2.99B	1.05%3.37B	-8.40%3.34B	-8.40%3.34B	432.97%3.65B	432.97%3.65B	-296.73%-1.09B	---1.09B	---275.96M
Total equity and non-current liabilities	0.45%3.57B	8.05%3.84B	-7.06%3.55B	-7.06%3.55B	749.97%3.82B	749.97%3.82B	-23.39%449.71M	--449.71M	--586.99M
Equity
Share capital	-0.59%169K	-0.59%169K	-0.58%170K	-0.58%170K	280.00%171K	280.00%171K	0.00%45K	--45K	--45K
Reserve	-10.60%2.99B	1.01%3.37B	-8.51%3.34B	-8.51%3.34B	433.53%3.65B	--3.65B	---1.09B	----	----
Legal reserve	-10.60%2.99B	1.01%3.37B	-8.51%3.34B	-8.51%3.34B	433.53%3.65B	--3.65B	---1.09B	----	----
Special items of shareholders' rights and interests	100.00%2K	100.00%2K	--1K	--1K	----	----	----	---1.09B	---276M
Shareholders' Equity	-10.60%2.99B	1.01%3.37B	-8.51%3.34B	-8.51%3.34B	433.56%3.65B	433.56%3.65B	-296.64%-1.09B	---1.09B	---275.96M
Non-controlling interest	146.92%502K	110.09%108K	80.85%-1.07M	80.85%-1.07M	-2,008.68%-5.59M	-2,008.68%-5.59M	---265K	---265K	----
Total equity	-10.55%2.99B	1.05%3.37B	-8.40%3.34B	-8.40%3.34B	432.97%3.65B	432.97%3.65B	-296.73%-1.09B	---1.09B	---275.96M
Total equity and total liabilities	-1.26%3.88B	3.44%4.07B	-0.05%3.93B	-0.05%3.93B	642.43%3.93B	642.43%3.93B	-19.53%529.95M	--529.95M	--658.58M
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS
Audit Opinions	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion
Auditor	Ernst & Young	--	Ernst & Young	--	Ernst & Young	--	Ernst & Young	--	Ernst & Young

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

02162 KEYMED BIO-B

KEYMED BIO-B Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Analysis

Analyst Rating

Price Target